PETALING JAYA: More can be done to advance Malaysia’s standing as the main hub for clinical research in the region, says a health expert.
Even though the country has seen positive growth in sponsored clinical research, raking in over RM1.16bil in cumulative gross national income since 2012, Prof Dr Sazaly Abu Bakar said there are areas that should be improved to level up Malaysia’s position as the main country in the field.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
